The Innovative Health Initiative will see the scope of joint research between industry, academics and SMEs expand beyond pharmaceuticals, to include medical technology, biotech, digital health and vaccines
During the 2014-16 Ebola outbreak in western Africa, public health expert Nicolas Meda of Burkina Faso played a key role in his country’s response to the epidemic. In an interview, he sets out the lessons learnt from the experience.
Advanced therapies feature in new Innovative Medicines Initiative Calls for proposals, along with topics on artificial intelligence; the need for reliable, relevant health information; and ways of incorporating patients’ perspectives into healthcare and cancer clinical trials.
IMI has involved patients in its projects and activities since the beginning. Now, IMI is creating a pool of patient experts to strengthen the role and voice of patients in IMI activities at strategic and operational levels.